PetMed Express Inc. (PETS) CEO Menderes Akdag Sells 10,000 Shares
PetMed Express Inc. (NASDAQ:PETS) CEO Menderes Akdag sold 10,000 shares of the stock in a transaction on Monday, October 10th. The stock was sold at an average price of $21.00, for a total transaction of $210,000.00. Following the sale, the chief executive officer now owns 600,000 shares of the company’s stock, valued at approximately $12,600,000. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
Menderes Akdag also recently made the following trade(s):
- On Thursday, September 22nd, Menderes Akdag sold 10,000 shares of PetMed Express stock. The stock was sold at an average price of $20.75, for a total transaction of $207,500.00.
Shares of PetMed Express Inc. (NASDAQ:PETS) opened at 20.32 on Wednesday. The stock has a 50 day moving average of $20.41 and a 200 day moving average of $19.28. PetMed Express Inc. has a 1-year low of $15.61 and a 1-year high of $21.16. The firm has a market cap of $410.06 million, a PE ratio of 19.35 and a beta of 1.07.
PetMed Express (NASDAQ:PETS) last posted its earnings results on Monday, July 25th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.01. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. The business had revenue of $72.50 million for the quarter. During the same period in the previous year, the firm posted $0.29 earnings per share. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. Equities research analysts anticipate that PetMed Express Inc. will post $1.11 earnings per share for the current fiscal year.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. NEXT Financial Group Inc boosted its position in PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock worth $100,000 after buying an additional 3,350 shares during the last quarter. BNP Paribas Arbitrage SA boosted its position in PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock worth $116,000 after buying an additional 3,121 shares during the last quarter. Royal Bank of Canada boosted its position in PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock worth $120,000 after buying an additional 1,053 shares during the last quarter. Cutler Group LP boosted its position in PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock worth $132,000 after buying an additional 8,029 shares during the last quarter. Finally, Bank of Montreal Can purchased a new position in PetMed Express during the second quarter worth approximately $143,000. 75.97% of the stock is currently owned by institutional investors and hedge funds.
A number of analysts recently weighed in on the stock. Zacks Investment Research cut shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 11th. Credit Suisse Group AG reiterated a “sell” rating and set a $13.00 price target on shares of PetMed Express in a research note on Tuesday, August 16th.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.